Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Weight-based enoxaparin thromboprophylaxis after caesarean section
ACTRN12611001003965Phase 4Recruiting
- Sponsor
- Mercy Hospital for Women
- Start
- Sep 2011
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of enoxaparin in venous thromboembolism (VTE), sponsored by Mercy Hospital for Women. Started Sep 2011; status: recruiting.
02
Drugs
enoxaparin
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on ACTRN12611001003965.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12611001003965.